What was Pure Bioscience’s price range in the past 12 months?
Pure Bioscience lowest stock price was $0.06 and its highest was $0.17 in the past 12 months.
What is Pure Bioscience’s market cap?
Currently, no data Available
When is Pure Bioscience’s upcoming earnings report date?
Pure Bioscience’s upcoming earnings report date is Jun 12, 2024 which is in 48 days.
How were Pure Bioscience’s earnings last quarter?
Pure Bioscience released its earnings results on Mar 18, 2024. The company reported -$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.009.
Pure Bioscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pure Bioscience have?
Pure Bioscience has 111,856,476 shares outstanding.
What happened to Pure Bioscience’s price movement after its last earnings report?
Pure Bioscience reported an EPS of -$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Pure Bioscience?
Currently, no hedge funds are holding shares in PURE
PURE Bioscience, Inc. engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in Rancho Cucamonga, CA.